These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Philipp W; Speicher L; Humpel C Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562 [TBL] [Abstract][Full Text] [Related]
34. [Experimental approaches to study in vivo angiogenesis]. Kilarski W; Bikfalvi A Bull Cancer; 2007 Jul; 94 Spec No():S166-9. PubMed ID: 17846001 [TBL] [Abstract][Full Text] [Related]
35. In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis. Conrad TJ; Chandler DB; Corless JM; Klintworth GK Lab Invest; 1994 Mar; 70(3):426-34. PubMed ID: 7511717 [TBL] [Abstract][Full Text] [Related]
36. A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents. Hosseini H; Nejabat M Med Hypotheses; 2007; 68(4):799-801. PubMed ID: 17107753 [TBL] [Abstract][Full Text] [Related]
37. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Bachmann B; Taylor RS; Cursiefen C Ophthalmology; 2010 Jul; 117(7):1300-5.e7. PubMed ID: 20605214 [TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Ma X; Ottino P; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102 [TBL] [Abstract][Full Text] [Related]
39. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Cursiefen C; Colin J; Dana R; Diaz-Llopis M; Faraj LA; Garcia-Delpech S; Geerling G; Price FW; Remeijer L; Rouse BT; Seitz B; Udaondo P; Meller D; Dua H Br J Ophthalmol; 2012 Jan; 96(1):3-9. PubMed ID: 21712359 [TBL] [Abstract][Full Text] [Related]
40. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. Benelli U; Bocci G; Danesi R; Lepri A; Bernardini N; Bianchi F; Lupetti M; Dolfi A; Campagni A; Agen C; Nardi M; Del Tacca M Exp Eye Res; 1998 Aug; 67(2):133-42. PubMed ID: 9733580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]